rosiglitazone has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knoll, E; Limor, R; Many, A; Sharon, O; Stern, N; Weisinger, G | 1 |
1 other study(ies) available for rosiglitazone and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Lipoxygenase-derived metabolites are regulators of peroxisome proliferator-activated receptor gamma-2 expression in human vascular smooth muscle cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Cells, Cultured; Gene Expression; Humans; Hydroxyeicosatetraenoic Acids; Hypoglycemic Agents; Muscle, Smooth, Vascular; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Umbilical Cord; Up-Regulation | 2008 |